|Page (1) of 1 - 05/21/12||email article||print page|
Market Research Forecasts Autoimmune Disorders Therapeutics Market at $61 Billion by 2017(May 21, 2012)
ROCKVILLE, MD -- (Marketwire) -- 05/21/12 -- MarketResearch.com has announced the addition of the new report "Autoimmune Disorders Therapeutics Market to 2017 -- Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments" to their collection of Diseases & Conditions market reports. For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Autoimmune-Disorders-Therapeutics-Launch-Gilenya-6927052/
GBI Research's analysis shows that the autoimmune disorders therapeutics market, comprising RA, MS, psoriasis, IBDs (CD and UC) and SLE, was worth $16.9 billion in 2002 and grew at a Compound Annual Growth Rate (CAGR) of 7.5% to $30.2 billion in 2010. It is forecast to reach $61.4 billion in 2017, indicating a CAGR of 10.7% during the forecast period. The average Annual Cost of Treatment (ACT) for autoimmune disorders therapeutics is increasing, and is expected to reach $12,073 by 2017, resulting in steady increase of the overall market during the forecast period. Growth in the major markets of the US, the top five countries of Europe, and Japan was driven by new developments that have created more treatment options for these indications. The future of the global market is therefore based on the success of the drugs in the pipeline.
The report provides in-depth analysis of the main autoimmune diseases, which are Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), Psoriasis, Inflammatory Bowel Disease (IBD) including Crohn's Disease (CD) and Ulcerative Colitis (UC), and Systemic Lupus Erythematosus (SLE). The report also gives the share of generic drugs in global autoimmune diseases, as well as in each indication's market. It examines global autoimmune diseases treatment usage patterns and the geographical distribution of autoimmune diseases and the markets in the US, the top five countries of Europe, and Japan. Also included are insights into the R&D product pipeline and profiles of major players.
For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Autoimmune-Disorders-Therapeutics-Launch-Gilenya-6927052/
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Veronica Franco at 240-747-3016 or visit http://www.marketresearch.com.
Copyright @ Marketwire
Related Keywords: MarketResearch.com, Japan, Marketwire, , Disease, Surgery, Medication, Medical,